Table 1.
Clinical characteristics of NSCLC patients
| Items | Total patients (N = 460) |
|---|---|
| Age (y), mean ± SD | 61.9 ± 9.7 |
| Gender, No. (%) | |
| Female | 102 (22.2) |
| Male | 358 (77.8) |
| History of smoke, No. (%) | 250 (54.3) |
| History of drink, No. (%) | 178 (38.7) |
| Hypertension, No. (%) | 174 (37.8) |
| Hyperlipidemia, No. (%) | 143 (31.1) |
| Diabetes, No. (%) | 81 (17.6) |
| Pathological differentiation, No. (%) | |
| Well | 68 (14.8) |
| Moderate | 298 (64.8) |
| Poor | 94 (20.4) |
| Tumor size (cm), mean ± SD | 5.1 ± 2.1 |
| LYN metastasis, No. (%) | 123 (26.7) |
| TNM stage, No. (%) | |
| I | 193 (42.0) |
| II | 167 (36.3) |
| III | 100 (21.7) |
| CEA (ng/mL), median (IQR) | 6.5 (2.9‐23.4) |
Abbreviations: CEA, carcinoembryonic antigen; IQR, interquartile range; LYN, lymph node; NSCLC, non‐small cell lung cancer; SD, standard deviation.